← Leaderboards
Xiao-Ping Li
Rutgers, The State Univ Of N.J.
$2,085,073
Attributed
$2,085,073
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $527.2K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,085,073 · 1
By mechanism
R01$2,085,073 · 1
Top collaborators
No co-investigators on record.
Most similar at Rutgers, The State Univ Of N.J.
Same institution · by research overlap
- Rong Di$151,889
- Sarah Potgieter$100,232
Others in their field
Other Emerging Leaders on “Acute Kidney Failure”
- Vera Hoffman · Reveal Pharma$11,205,165
- Marlena Habal · Columbia University Health Sciences$5,428,816
- Javier A. Neyra · University Of Kentucky$4,703,171
- Dennis G. Moledina · Yale University$4,592,286
- Arun Sharma · Northwestern University At Chicago$4,071,997
- Meghan E. Sise · Massachusetts General Hospital$3,964,291
Research focus
Acute Kidney FailureAdenineAffinityAnalogAntibioticsAntibiotic TherapyAntidotesApoptosisAssay DevelopmentBacteriophagesBaseBindingBinding ProteinsBinding SitesBiochemicalBiological Adaptation To StressCatalytic DomainCategoriesCategory B PathogenCellsChildComplexCryoelectron MicroscopyActive Sites
Grant awards (4)
Assay development and screening for inhibitors targeting Shiga toxin 2$511,743
R01 · FY2022 · AI · contact PI
Assay development and screening for inhibitors targeting Shiga toxin 2$519,493
R01 · FY2021 · AI · contact PI
Assay development and screening for inhibitors targeting Shiga toxin 2$527,243
R01 · FY2020 · AI · contact PI
Assay development and screening for inhibitors targeting Shiga toxin 2$526,594
R01 · FY2019 · AI · contact PI